The effect of sialoglycopeptide (GP) derived from fetuin on the tissue distribution of
Previously, we demonstrated that modifying the surface of small unilamellar vesicles (SUV) with sialoglycopeptide (GP) derived from fetuin inhibited their clearance from the circulation of rats.2) However, the relationship between the clearance of GP-SUV and its uptake by hepatic tissue was not examined.
Recently, Allen and Chonn3) have shown that gangliosides and sphingomyelin dramatically diminish the rate and extent of uptake of liposomes by macrophages in vivo. The role of cell surface carbohydrates, in particular the surface sialic acid residues in cellular antirecognition phenomena is widely appreciated.4-6) Therefore, a series of experiments were conducted to determine the effect of GP-modification on the tissue distribution of intravenously administered SUV. Our results show that the liver uptake of SUV can be significantly inhibited by the GP-modification of the liposomal membrane. (
DA is the injected radioactivity of [3H]inulin and Vd is the apparent volume of distribution, which was estimated from Eq. 2.
The zero-time intercept obtained by extrapolation of the initial linear portion of the percentage of dose versus time plot to t =0 is CA (t = 0). Radioactivities in heart, liver, kidney, lung, spleen and urine were calculated and expressed as percent of the dose. level of radioactivity in the urine was increased with increasing amount of GP-modification. The tissue distribution of liposomal radioactivity at 30 min and 3 h after the administration of GP-SUV (GP/PE = 0.01; equivalent normal weight diameter, 101.3 nm) is shown in Fig. 2 . The 3H level in liver reached 20% by 30 min post-injection, and about 14% was present in urine and 8% in the kidney. The major fraction (52%) was found in the blood. By 3 h, the blood level of radioactivity had decreased to 30%, while the 3H level in liver had increased by 9% and that in the urine by 11 %. When free inulin was administered intravenously in rats, it was cleared rapidly by the kidney and excreted into urine. Abra et al. reported that the half-life for free inulin averaged 15 min with approximately 0.6% of the dose remaining in blood, 2.5% in the liver, and 0.15% in the spleen at 1 h post-injection.8) Therefore, free [3H]inulin in this study probably made no significant contribution to the measurement of GP-liposomal tissue distribution. As the lipid composition and the size distribution of GP-SUV were essentially the same as the control SUV, the difference in the tissue distribution can be substantially accounted for by the amount of GP-modification. Earlier, we reported that the latency of SUV in pooled plasma was reduced by GP-modification.
Results and Discussion
2) The increase of 3H level in urine associated with the increase of GP-modification may be due to the leakage of [3H]inulin through the liposomal membrane. In contrast, the liver uptake was decreased with an increase of GP-modification. It is conceivable that the decreased liver uptake over 3 h may have been due to the leakage of [3H]inulin from the GP-modified liposomes. To examine this possiblility, estimated tissue levels were calculated from Eq. 2 assuming no leakage of [3H]inulin from liposomes, and the results are shown in Table I . If the leaked [3H]inulin is recovered completely in urine, the following equation may be written for estimated tissue levels. (3) Where x' and x are estimated and observed percentage of dose in each tissue, respectively and u is observed urinary percentage of dose. The estimated 31-1 levels in liver were 27.7, 43.9 and 49.6% at GP/PE equal to 0.022, 0.015 and 0 (control), respectively (Table I) . Thus, the liver uptake of liposomal inulin was decreased significantly, even when the leakage of marker by GP-modification is taken into consideration. In addition, a greater fraction of the dose remained at 3 h after the administration of GP-liposomes (GP/PE = 0.022) compared to when control liposomes were administered.
In the present study it was shown that the clearance from the circulation and liver uptake of GP-SUV were significantly influenced by a small change of the GP/PE ratio. The change of this ratio from 0.015 to 0.022 corresponded to an increase of sialic acid residues of 0.1 /mot, since GP has three sialic acid residues. The studies reported by Allen and Chonn3) on the liver uptake of monosialylganglioside (GM1)-modified large unilamellar liposomes (LUV) have also indicated that the liver uptake of LUV was decreased by about 10% with an increase of GM1 content which was comparable with the increase of sialic acid residues in our experiment. The disposition of GP-SUV seems to be greatly affected by the amount of GP-modification.
It is generally accepted that MLV are mainly taken up by the Kupffer cells, while SUV (smaller than 100 nm) are taken up by parenchymal cells.9) It has also been reported that the phagocytosis of liposomes by macrophages was diminished by the binding of sialoglycoprotein to the liposome surface,10) and that the phagocytic reaction of human PMN cells was markedly suppressed when the sialoglycoprotein of human erythrocytes was incorporated into liposomes.11) However, it is unclear which uptake (by Kupffer cells of parenchymal cells) was inhibited by GP-modification of SUV. Further studies are under way to investigate the distribution of GP-liposomes within the liver cell fraction.
